NewsNovo
StockStory analysts advise against adding Ameresco to a portfolio, citing persistent cash flow deficits and a heavy debt load.
Despite a 19.2% decline in Ameresco's stock price over the past six months to $21.01, the firm argues that the lower entry price does not offset fundamental risks.
This underperformance contrasts sharply with the S&P 500's 14.3% gain during the same period. The primary concern is that Ameresco has become less profitable on a per-share basis as it has expanded.
Over the last five years, earnings per share declined by 15.7% annually, even as revenue grew by 12.5%.
Keep reading